In Westport, an Irish town transformed by a pharmaceutical plant that manufactures the world’s Botox, there are fears ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a study titled An Open-label ...

In addition to Cantor Fitzgerald, AbbVie also received a Buy from Piper Sandler’s David Amsellem in a report issued yesterday. However, on August 4, Bernstein maintained a Hold rating on AbbVie (NYSE: ...

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

Key Points Collaboration and license revenue (GAAP) for Q2 2025 was $8.1 million but missed Q2 2025 GAAP revenue estimates by $0.11 million. Net loss (GAAP) widened to $15.8 million, with increased ...

The Trump administration is touting a series of major manufacturing announcements, with companies pledging billions in U.S.

This clinical study update could influence AbbVie’s stock performance by showcasing its commitment to innovative cancer treatments. Positive outcomes may enhance investor confidence and position ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

The sharp profit fall was due to a provision of $37.75 million made by Glenmark to settle US antitrust and consumer ...

Vendanta's CEO also announced the company is cutting 20% of its workforce as a result of the Phase II UC trial failure.

Schrödinger is discontinuing the development of its blood cancer CDC7 inhibitor after two patient deaths. In a Phase I trial ...